Completed NA INTERVENTIONAL 2-arm NCT01688154

Ability of Grape Seed Proanthocyanidins to Reduce Postprandial Triglycerides in Humans

Sponsor: Hospital Universitari Sant Joan de Reus

Conditions Cardiovascular Function Triglyceride Metabolism

Interventions 2 empty capsules 35 mg/Kg of grape seed proanthocyanidins extract (2 capsules)

Updated 5 times since 2017 Last updated: Jul 2, 2013 Started: Feb 28, 2013 Primary completion: May 31, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiovascular Function and Triglyceride Metabolism and is currently completed. Hospital Universitari Sant Joan de Reus leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Feb 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitari Sant Joan de Reus
Technological Centre of Nutrition and Health, Spain
University Rovira i Virgili

Data source: Technological Centre of Nutrition and Health, Spain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Reus, Spain